• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 10623
Device Problems Positioning Failure (1158); Device-Device Incompatibility (2919); Material Deformation (2976); Material Integrity Problem (2978)
Patient Problem No Code Available (3191)
Event Date 03/20/2019
Event Type  Injury  
Manufacturer Narrative
Device is combination product.
 
Event Description
It was reported that stent damage occurred.The target lesion was located in the rca.This 3.00 x 38 synergy stent was selected.During advancement through a guidezilla ii guide extension catheter, the balloon became caught on the collar of the guidezilla.The distal end of the synergy stent was pierced, which led to non-deployment of the stent and longitudinal compression.The synergy stent was finally implanted, but new complex stenting was required which may have increased the risk of thrombosis the patient did not experience thrombosis and the procedure was successfully complete.No patient complications were reported.
 
Manufacturer Narrative
Device is combination product device evaluated by mfr:a synergy ous mr 3.00 x 38mm stent delivery system was returned for analysis without a stent.The balloon was reviewed.There was no stent on the balloon.Stent crimp markings were evident on balloon.The balloon folds were present but relaxed from the original tightly folded condition.What appeared to be contrast media solution was evident in the balloon and inflation lumen.A leak test was carried out using encore inflation device, when pressure was applied a pinhole leak was noted in the balloon material at the distal markerband site.A visual and tactile examination of the hypotube found multiple hypotube kinks.A visual and tactile examination of the shaft polymer extrusion revealed no issues.A visual and microscopic examination of the tip found tip damage.No other issues were identified during the product analysis.
 
Event Description
It was reported that stent damage occurred.The target lesion was located in the rca.This 3.00 x 38 synergy stent was selected.During advancement through a guidezilla ii guide extension catheter, the balloon became caught on the collar of the guidezilla.The distal end of the synergy stent was pierced, which led to non-deployment of the stent and longitudinal compression.The synergy stent was finally implanted, but new complex stenting was required which may have increased the risk of thrombosis the patient did not experience thrombosis and the procedure was successfully complete.No patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key8528423
MDR Text Key142389411
Report Number2134265-2019-04067
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 06/04/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/18/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/19/2020
Device Model Number10623
Device Catalogue Number10623
Device Lot Number0023242482
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/18/2019
Date Manufacturer Received05/13/2019
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-